CH616691A5 - Process for the preparation of steroid compounds and their use. - Google Patents
Process for the preparation of steroid compounds and their use. Download PDFInfo
- Publication number
- CH616691A5 CH616691A5 CH1837071A CH1837071A CH616691A5 CH 616691 A5 CH616691 A5 CH 616691A5 CH 1837071 A CH1837071 A CH 1837071A CH 1837071 A CH1837071 A CH 1837071A CH 616691 A5 CH616691 A5 CH 616691A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- compounds
- methyl
- hydroxy
- methyl group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6006470A GB1380246A (en) | 1970-12-17 | 1970-12-17 | 3alpha-hydroxy-androstanes and esters thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CH616691A5 true CH616691A5 (en) | 1980-04-15 |
Family
ID=10484935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1837071A CH616691A5 (en) | 1970-12-17 | 1971-12-16 | Process for the preparation of steroid compounds and their use. |
Country Status (9)
Country | Link |
---|---|
AU (1) | AU473167B2 (da) |
BE (1) | BE776786A (da) |
CA (1) | CA988508A (da) |
CH (1) | CH616691A5 (da) |
DE (1) | DE2162555A1 (da) |
DK (1) | DK133682B (da) |
FR (1) | FR2118117B1 (da) |
IL (1) | IL38376A (da) |
ZA (1) | ZA718466B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1434919A (en) * | 1972-06-15 | 1976-05-12 | Glaxo Lab Ltd | 3alpha-hydroxy androstanes |
US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
EP0701444B1 (en) | 1993-05-24 | 2010-04-07 | Purdue Pharma Ltd. | Methods and compositions for inducing sleep |
CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
US2824871A (en) * | 1951-11-29 | 1958-02-25 | Upjohn Co | Steroid compounds and process |
FR1281205A (fr) * | 1956-12-21 | 1962-01-12 | Organon Nv | Procédé d'obtention de composés de la série du prégnane |
-
1971
- 1971-12-16 IL IL38376A patent/IL38376A/en unknown
- 1971-12-16 BE BE776786A patent/BE776786A/xx unknown
- 1971-12-16 CA CA130,275A patent/CA988508A/en not_active Expired
- 1971-12-16 AU AU36962/71A patent/AU473167B2/en not_active Expired
- 1971-12-16 DK DK614771AA patent/DK133682B/da unknown
- 1971-12-16 FR FR7145225A patent/FR2118117B1/fr not_active Expired
- 1971-12-16 DE DE19712162555 patent/DE2162555A1/de not_active Ceased
- 1971-12-16 CH CH1837071A patent/CH616691A5/de not_active IP Right Cessation
- 1971-12-17 ZA ZA718466A patent/ZA718466B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU473167B2 (en) | 1976-06-17 |
DE2162555A1 (de) | 1972-06-22 |
FR2118117B1 (da) | 1975-12-26 |
CA988508A (en) | 1976-05-04 |
ZA718466B (en) | 1973-08-29 |
BE776786A (fr) | 1972-06-16 |
IL38376A0 (en) | 1972-02-29 |
IL38376A (en) | 1977-07-31 |
DK133682B (da) | 1976-06-28 |
FR2118117A1 (da) | 1972-07-28 |
AU3696271A (en) | 1973-06-21 |
DK133682C (da) | 1976-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH617710A5 (en) | Process for the preparation of steroids of the pregnane or 19-norpregnane series with anaesthetic activity | |
DE2438020A1 (de) | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung | |
DE2030402C3 (da) | ||
DE2222491C3 (de) | Steroid-21-salpetersäureester der Pregnanreihe, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
DE2330342A1 (de) | Steroidverbindungen | |
CH620226A5 (da) | ||
CH616691A5 (en) | Process for the preparation of steroid compounds and their use. | |
DE2162594A1 (de) | 3 alpha-oxygenierte Pregnan-21-äther und Verfahren zu deren Herstellung | |
DE2162592A1 (de) | Steroide der 5 alpha-Pregnan-Reihen | |
CH494216A (de) | Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden | |
CH640247A5 (de) | Steroid-spiro-oxazolidone und verfahren zu ihrer herstellung. | |
DE2255153A1 (de) | Neue steroidverbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
DE1807585C3 (de) | 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
EP0063368B1 (de) | Verfahren zur Herstellung von Pregn-4-en-3,20-dionderivaten sowie 17-alpha-Äthinyl-17-beta-trifluoracetoxygon-4-en-3-onderivate und die letzteren enthaltende Arzneimittel | |
CH526526A (de) | Verfahren zur Herstellung eines neuen 6a-Methyl-19-nor-progesterons | |
DE2204360C2 (de) | Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
DE1493313C (de) | 16b, 17 Cycloenolather des 17alpha Hydroxy öalpha methyl 3,20 dioxo 4 pregnen 16alpha acetaldehyds und des 1 lbeta, 17alpha Dihydroxy 9alpha fluor 6alpha methyl 3,20 dioxo 1,4 pregnadien 16alpha acetaldehyds und Verfahren zu ihrer Herstellung | |
DE1668857C (de) | 6 alpha, 9 alpha Difluorprednisolon 17 valerat 21 acetat | |
DE2322550A1 (de) | Pregnanderivate und verfahren zu ihrer herstellung | |
DE1199262C2 (de) | Verfahren zur Herstellung von 5alpha-Brom-6beta-hydroxysteroiden | |
DE964775C (de) | Verfahren zur Herstellung von Steroid-17-carbonsaeuren bzw. von Steroid-17-ketonen | |
DE2056512C3 (da) | ||
DE1668859C (de) | 6 alpha, 9 alpha Difluorhydrocortison bzw prednisolon 17 valerat | |
DE2017533C3 (de) | Neue Carbonatester von 6alpha, 9alpha-Difluor-11beta, 16alpha, 17alpha, 21 -tetrahydroxy-pregna-1,4-dien-3,20dion-16alpha-17alpha-acetonid, Verfahren zu deren Herstellung sowie diese enthaltendes Mittel | |
DE1105412B (de) | Verfahren zur Herstellung von ?-3-Keto-6ª-methylsteroiden der Androstan- und Pregnanreihe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |